Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verge, C. F.
Right arrow Articles by Eisenbarth, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verge, C. F.
Right arrow Articles by Eisenbarth, G. S.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 47, Issue 12 1857-1866, Copyright © 1998 by American Diabetes Association

ARTICLES

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop

CF Verge, D Stenger, E Bonifacio, PG Colman, C Pilcher, PJ Bingley and GS Eisenbarth
Sydney Children's Hospital, Randwick, New South Wales, Australia.

The aim of this workshop was to assess the ability of individual autoantibody (ab) assays and their use in combination to discriminate between type 1 diabetic and control sera. Coded aliquots of sera were measured in a total of 119 assays by 49 participating laboratories in 17 countries. The sera were from 51 patients with new onset type 1 diabetes and 101 healthy control subjects with no family history of diabetes. In the final analysis, data on diabetic sera were restricted to 43 subjects younger than age 30 years. The laboratories were asked to report results for these sera using their currently available anti-islet autoantibody assays. In addition, they were asked to combine information from their assays to classify sera as having high, moderate, or low probability of originating from a patient with type 1 diabetes. Actual strategies for combining assays were determined by each laboratory. There were no significant differences in sensitivity among 19 radioimmunoassays (RIAs) for IA-2 autoantibodies (cytoplasmic islet cell antibody [ICA] 512) using different constructs that included the intracellular portion of the molecule (mean sensitivity 73%). However, an enzyme-linked immunosorbent assay (ELISA) using the extracellular portion of the IA-2 molecule did not discriminate between diabetic and control sera. Among GAD autoantibody assays that achieved sensitivity >70%, 26 were RIAs and one was an ELISA. When the sera were ranked according to their autoantibody levels, the concordance for insulin autoantibodies (IAAs) in different laboratories was markedly less than for IA-2ab and GADab. Using a combination of autoantibody assays, several laboratories achieved excellent discrimination between diabetic and control sera (sensitivity up to 80% with false-positive rate of 0%). A variety of strategies for combining information from different assays were successful (e.g., those including and excluding ICA), and no one strategy emerged as clearly superior. In conclusion, IA-2/ICA512 autoantibodies are a marker of type 1 diabetes and can be measured consistently by most assays. Several different strategies for combining assays achieved high sensitivity with a low false-positive rate.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
C. Tiberti, C. Giordano, M. Locatelli, E. Bosi, G. F. Bottazzo, R. Buzzetti, D. Cucinotta, A. Galluzzo, A. Falorni, and F. Dotta
Identification of Tyrosine Phosphatase 2(256-760) Construct as a New, Sensitive Marker for the Detection of Islet Autoimmunity in Type 2 Diabetic Patients: The Non-Insulin Requiring Autoimmune Diabetes (NIRAD) Study 2
Diabetes, May 1, 2008; 57(5): 1276 - 1283.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Goel, H. Chiu, J. Felton, J. P. Palmer, and B. Brooks-Worrell
T-Cell Responses to Islet Antigens Improves Detection of Autoimmune Diabetes and Identifies Patients With More Severe {beta}-Cell Lesions in Phenotypic Type 2 Diabetes
Diabetes, August 1, 2007; 56(8): 2110 - 2115.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Buzzetti, S. Di Pietro, A. Giaccari, A. Petrone, M. Locatelli, C. Suraci, M. Capizzi, M. L. Arpi, E. Bazzigaluppi, F. Dotta, et al.
High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune Diabetes
Diabetes Care, April 1, 2007; 30(4): 932 - 938.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. S. Hampe, R. Nalini, M. R. Maldonado, T. R. Hall, G. Garza, D. Iyer, and A. Balasubramanyam
Association of Amino-Terminal-Specific Antiglutamate Decarboxylase (GAD65) Autoantibodies with {beta}-Cell Functional Reserve and a Milder Clinical Phenotype in Patients with GAD65 Antibodies and Ketosis-Prone Diabetes Mellitus
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 462 - 467.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Q. Ouyang, N. E. Standifer, H. Qin, P. Gottlieb, C. B. Verchere, G. T. Nepom, R. Tan, and C. Panagiotopoulos
Recognition of HLA Class I-Restricted {beta}-Cell Epitopes in Type 1 Diabetes
Diabetes, November 1, 2006; 55(11): 3068 - 3074.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
K. M. Gillespie
Type 1 diabetes: pathogenesis and prevention.
Can. Med. Assoc. J., July 18, 2006; 175(2): 165 - 170.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. Fourlanos, C. Perry, M. S. Stein, J. Stankovich, L. C. Harrison, and P. G. Colman
A Clinical Screening Tool Identifies Autoimmune Diabetes in Adults
Diabetes Care, May 1, 2006; 29(5): 970 - 975.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. M. Sosenko, J. P. Palmer, C. J. Greenbaum, J. Mahon, C. Cowie, J. P. Krischer, H. P. Chase, N. H. White, B. Buckingham, K. C. Herold, et al.
Patterns of metabolic progression to type 1 diabetes in the diabetes prevention trial-type 1.
Diabetes Care, March 1, 2006; 29(3): 643 - 649.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. Mrena, S. M. Virtanen, P. Laippala, P. Kulmala, M.-L. Hannila, H. K. Akerblom, M. Knip, and the Childhood Diabetes in Finland Study Group
Models for predicting type 1 diabetes in siblings of affected children.
Diabetes Care, March 1, 2006; 29(3): 662 - 667.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. G. M. Pinkse, O. H. M. Tysma, C. A. M. Bergen, M. G. D. Kester, F. Ossendorp, P. A. van Veelen, B. Keymeulen, D. Pipeleers, J. W. Drijfhout, and B. O. Roep
Autoreactive CD8 T cells associated with {beta} cell destruction in type 1 diabetes
PNAS, December 20, 2005; 102(51): 18425 - 18430.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. J. Glastras, M. E. Craig, C. F. Verge, A. K. Chan, J. M. Cusumano, and K. C. Donaghue
The Role of Autoimmunity at Diagnosis of Type 1 Diabetes in the Development of Thyroid and Celiac Disease and Microvascular Complications
Diabetes Care, September 1, 2005; 28(9): 2170 - 2175.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. J. Woodward and J. W. Thomas
Multiple Germline {kappa} Light Chains Generate Anti-Insulin B Cells in Nonobese Diabetic Mice
J. Immunol., July 15, 2005; 175(2): 1073 - 1079.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
B. J. Hering, R. Kandaswamy, J. D. Ansite, P. M. Eckman, M. Nakano, T. Sawada, I. Matsumoto, S.-H. Ihm, H.-J. Zhang, J. Parkey, et al.
Single-Donor, Marginal-Dose Islet Transplantation in Patients With Type 1 Diabetes
JAMA, February 16, 2005; 293(7): 830 - 835.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. A. Acevedo-Suarez, C. Hulbert, E. J. Woodward, and J. W. Thomas
Uncoupling of Anergy from Developmental Arrest in Anti-Insulin B Cells Supports the Development of Autoimmune Diabetes
J. Immunol., January 15, 2005; 174(2): 827 - 833.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Maioli, E. Alejandro, G. Tonolo, L. K. Gilliam, L. Bekris, C. S. Hampe, D. A. Obinu, A. Manconi, L. Puddu, K. Lynch, et al.
Epitope-Restricted 65-Kilodalton Glutamic Acid Decarboxylase Autoantibodies among New-Onset Sardinian Type 2 Diabetes Patients Define Phenotypes of Autoimmune Diabetes
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5675 - 5682.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
F. J. Quintana, P. H. Hagedorn, G. Elizur, Y. Merbl, E. Domany, and I. R. Cohen
Functional immunomics: Microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes
PNAS, October 5, 2004; 101(suppl_2): 14615 - 14621.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
X. Palomer, D. Mauricio, J. Rodriguez-Espinosa, E. Zapico, C. Mayoral, F. Gonzalez-Sastre, A. de Leiva, and F. Blanco-Vaca
Evaluation of Two Nonisotopic Immunoassays for Determination of Glutamic Acid Decarboxylase and Tyrosine Phosphatase Autoantibodies in Serum
Clin. Chem., August 1, 2004; 50(8): 1378 - 1382.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Panagiotopoulos, H. Qin, R. Tan, and C. B. Verchere
Identification of a {beta}-Cell-Specific HLA Class I Restricted Epitope in Type 1 Diabetes
Diabetes, November 1, 2003; 52(11): 2647 - 2651.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Kibirige, B. Metcalf, R. Renuka, and T. J. Wilkin
Testing the Accelerator Hypothesis: The relationship between body mass and age at diagnosis of type 1 diabetes
Diabetes Care, October 1, 2003; 26(10): 2865 - 2870.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Mrena, K. Savola, P. Kulmala, H. Reijonen, J. Ilonen, H. K. Akerblom, and M. Knip
Genetic Modification of Risk Assessment Based on Staging of Preclinical Type 1 Diabetes in Siblings of Affected Children
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2682 - 2689.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. J. Greenbaum and L. C. Harrison
Guidelines for Intervention Trials in Subjects With Newly Diagnosed Type 1 Diabetes
Diabetes, May 1, 2003; 52(5): 1059 - 1065.
[Full Text] [PDF]

Home page
 DiabetesHome page
P. J. Bingley, E. Bonifacio, and P. W. Mueller
Diabetes Antibody Standardization Program: First Assay Proficiency Evaluation
Diabetes, May 1, 2003; 52(5): 1128 - 1136.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Hanifi-Moghaddam, N. C. Schloot, S. Kappler, J. Seissler, and H. Kolb
An Association of Autoantibody Status and Serum Cytokine Levels in Type 1 Diabetes
Diabetes, May 1, 2003; 52(5): 1137 - 1142.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Gianani and G. S. Eisenbarth
Autoimmunity to Gastrointestinal Endocrine Cells in Autoimmune Polyendocrine Syndrome Type I
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1442 - 1444.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. P. Krischer, D. D. Cuthbertson, L. Yu, T. Orban, N. Maclaren, R. Jackson, W. E. Winter, D. A. Schatz, J. P. Palmer, and G. S. Eisenbarth
Screening Strategies for the Identification of Multiple Antibody-Positive Relatives of Individuals with Type 1 Diabetes
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 103 - 108.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. W. Thomas, P. L. Kendall, and H. G. Mitchell
The Natural Autoantibody Repertoire of Nonobese Diabetic Mice Is Highly Active
J. Immunol., December 1, 2002; 169(11): 6617 - 6624.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Kotani, M. Nagata, H. Moriyama, M. Nakayama, K. Yamada, S. A. Chowdhury, S. Chakrabarty, Z. Jin, H. Yasuda, and K. Yokono
Detection of GAD65-Reactive T-Cells in Type 1 Diabetes by Immunoglobulin-Free ELISPOT Assays
Diabetes Care, August 1, 2002; 25(8): 1390 - 1397.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. R. Christie, J. Molvig, C. J. Hawkes, B. Carstensen, T. Mandrup-Poulsen, and the Canadian-European Randomised Control Trial Gro
IA-2 Antibody-Negative Status Predicts Remission and Recovery of C-Peptide Levels in Type 1 Diabetic Patients Treated With Cyclosporin
Diabetes Care, July 1, 2002; 25(7): 1192 - 1197.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. Weets, V. Siraux, J.-C. Daubresse, I. H. De Leeuw, F. Fery, B. Keymeulen, G. Krzentowski, M. Letiexhe, C. Mathieu, F. Nobels, et al.
Relation between Disease Phenotype and HLA-DQ Genotype in Diabetic Patients Diagnosed in Early Adulthood
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2597 - 2605.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
Diabetes Prevention Trial-Type 1 Diabetes Study Gr
Effects of Insulin in Relatives of Patients with Type 1 Diabetes Mellitus
N. Engl. J. Med., May 30, 2002; 346(22): 1685 - 1691.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
I. Weets, I. H. De Leeuw, M. V.L. Du Caju, R. Rooman, B. Keymeulen, C. Mathieu, R. Rottiers, J.-C. Daubresse, D. Rocour-Brumioul, D. G. Pipeleers, et al.
The Incidence of Type 1 Diabetes in the Age Group 0-39 Years Has Not Increased in Antwerp (Belgium) Between 1989 and 2000: Evidence for earlier disease manifestation
Diabetes Care, May 1, 2002; 25(5): 840 - 846.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. L. Lethagen, U.-B. Ericsson, B. Hallengren, L. Groop, and T. Tuomi
Glutamic Acid Decarboxylase Antibody Positivity Is Associated with an Impaired Insulin Response to Glucose and Arginine in Nondiabetic Patients with Autoimmune Thyroiditis
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1177 - 1183.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. B. Sacks, D. E. Bruns, D. E. Goldstein, N. K. Maclaren, J. M. McDonald, and M. Parrott
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
Clin. Chem., March 1, 2002; 48(3): 436 - 472.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Kupila, P. Keskinen, T. Simell, S. Erkkila, P. Arvilommi, S. Korhonen, T. Kimpimaki, M. Sjoroos, M. Ronkainen, J. Ilonen, et al.
Genetic Risk Determines the Emergence of Diabetes-Associated Autoantibodies in Young Children
Diabetes, March 1, 2002; 51(3): 646 - 651.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
L. Piemonti, B. E. Leone, R. Nano, A. Saccani, P. Monti, P. Maffi, G. Bianchi, A. Sica, G. Peri, R. Melzi, et al.
Human Pancreatic Islets Produce and Secrete MCP-1/CCL2: Relevance in Human Islet Transplantation
Diabetes, January 1, 2002; 51(1): 55 - 65.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. M. Gillespie, E. A.M. Gale, and P. J. Bingley
High Familial Risk and Genetic Susceptibility in Early Onset Childhood Diabetes
Diabetes, January 1, 2002; 51(1): 210 - 214.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Winer, I. Astsaturov, R. Gaedigk, D. Hammond-McKibben, M. Pilon, A. Song, V. Kubiak, W. Karges, E. Arpaia, C. McKerlie, et al.
ICA69null Nonobese Diabetic Mice Develop Diabetes, but Resist Disease Acceleration by Cyclophosphamide
J. Immunol., January 1, 2002; 168(1): 475 - 482.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Hulbert, B. Riseili, M. Rojas, and J. W. Thomas
Cutting Edge: B Cell Specificity Contributes to the Outcome of Diabetes in Nonobese Diabetic Mice
J. Immunol., November 15, 2001; 167(10): 5535 - 5538.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. Bonifacio, M. Atkinson, G. Eisenbarth, D. Serreze, T. W.H. Kay, E. Lee-Chan, and B. Singh
International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: Identification of Insulin but Not Glutamic Acid Decarboxylase or IA-2 as Specific Autoantigens of Humoral Autoimmunity in Nonobese Diabetic Mice
Diabetes, November 1, 2001; 50(11): 2451 - 2458.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. Bosi, S. Braghi, P. Maffi, M. Scirpoli, F. Bertuzzi, G. Pozza, A. Secchi, and E. Bonifacio
Autoantibody Response to Islet Transplantation in Type 1 Diabetes
Diabetes, November 1, 2001; 50(11): 2464 - 2471.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. Savola, E. Laara, P. Vahasalo, P. Kulmala, H. K. Akerblom, and M. Knip
Dynamic Pattern of Disease-Associated Autoantibodies in Siblings of Children With Type 1 Diabetes: A Population-Based Study
Diabetes, November 1, 2001; 50(11): 2625 - 2632.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Kimpimaki, A. Kupila, A.-M. Hamalainen, M. Kukko, P. Kulmala, K. Savola, T. Simell, P. Keskinen, J. Ilonen, O. Simell, et al.
The First Signs of {beta}-Cell Autoimmunity Appear in Infancy in Genetically Susceptible Children from the General Population: The Finnish Type 1 Diabetes Prediction and Prevention Study
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4782 - 4788.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. E. M. De Block, I. H. De Leeuw, K. Decochez, F. Winnock, J. Van Autreve, C. M. Van Campenhout, M. Martin, and F. K. Gorus
The Presence of Thyrogastric Antibodies in First Degree Relatives of Type 1 Diabetic Patients Is Associated with Age and Proband Antibody Status
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4358 - 4363.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. Jury, P. Sohnlein, M. Vogel, and W. Richter
Isolation and Functional Characterization of Recombinant GAD65 Autoantibodies Derived by IgG Repertoire Cloning From Patients With Type 1 Diabetes
Diabetes, September 1, 2001; 50(9): 1976 - 1982.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. Kelemen, D. R. Wegmann, and J. C. Hutton
T-Cell Epitope Analysis on the Autoantigen Phogrin (IA-2{beta}) in the Nonobese Diabetic Mouse
Diabetes, August 1, 2001; 50(8): 1729 - 1734.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
L. Yu, D. D. Cuthbertson, N. Maclaren, R. Jackson, J. P. Palmer, T. Orban, G. S. Eisenbarth, and J. P. Krischer
Expression of GAD65 and Islet Cell Antibody (ICA512) Autoantibodies Among Cytoplasmic ICA+ Relatives Is Associated With Eligibility for the Diabetes Prevention Trial-Type 1
Diabetes, August 1, 2001; 50(8): 1735 - 1740.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
F. Winnock, M. R. Christie, M. R. Batstra, H.-J. Aanstoot, I. Weets, K. Decochez, P. Jopart, D. Nicolaij, and F. K. Gorus
Autoantibodies to a 38-kDa Glycosylated Islet Cell Membrane-Associated Antigen in (Pre)type 1 Diabetes: Association with IA-2 and islet cell autoantibodies
Diabetes Care, July 1, 2001; 24(7): 1181 - 1186.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Lorini, A. Alibrandi, L. Vitali, C. Klersy, M. Martinetti, C. Betterle, G. d'Annunzio, and E. Bonifacio
Risk of Type 1 Diabetes Development in Children With Incidental Hyperglycemia: A multicenter Italian study
Diabetes Care, July 1, 2001; 24(7): 1210 - 1216.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Rickert, J. Seissler, W. Dangel, H. Lorenz, and W. Richter
Fusion Proteins for Combined Analysis of Autoantibodies to the 65-kDa Isoform of Glutamic Acid Decarboxylase and Islet Antigen-2 in Insulin-dependent Diabetes Mellitus
Clin. Chem., May 1, 2001; 47(5): 926 - 934.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. Umpaichitra, W. Bastian, D. Taha, M. A. Banerji, T. W. AvRuskin, and S. Castells
C-peptide and Glucagon Profiles in Minority Children with Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1605 - 1609.
[Abstract] [Full Text]

Home page
 GutHome page
B Wesche, E Jaeckel, C Trautwein, H Wedemeyer, A Falorni, H Frank, A von zur Muhlen, M-P Manns, and G Brabant
Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C
Gut, March 1, 2001; 48(3): 378 - 383.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. J. K. Williams, A. J. Norcross, R. J. Lock, D. J. Unsworth, E. A. M. Gale, and P. J. Bingley
The High Prevalence of Autoantibodies to Tissue Transglutaminase in First-Degree Relatives of Patients With Type 1 Diabetes Is Not Associated With Islet Autoimmunity
Diabetes Care, March 1, 2001; 24(3): 504 - 509.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
S. Trembleau, G. Penna, S. Gregori, G. Magistrelli, A. Isacchi, and L. Adorini
Early Th1 Response in Unprimed Nonobese Diabetic Mice to the Tyrosine Phosphatase-Like Insulinoma-Associated Protein 2, an Autoantigen in Type 1 Diabetes
J. Immunol., December 15, 2000; 165(12): 6748 - 6755.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Gylling, T. Tuomi, P. Björses, S. Kontiainen, J. Partanen, M. R. Christie, M. Knip, J. Perheentupa, and A. Miettinen
{beta}-Cell Autoantibodies, Human Leukocyte Antigen II Alleles, and Type 1 Diabetes in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy